Not Yet RecruitingNot Applicable

Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

300 participantsStarted 2026-03-30

Plain-language summary

This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female ≥ 18 years
✓. Histologically proven invasive or microinvasive squamous cell carcinoma of the anus
✓. Having read and understood the information letter provided, either:
✓. Affiliated with a social security system

Exclusion criteria

✕. Refusal to participate in the protocol
✕. Other histological types: lymphoma, adenocarcinoma, neuroendocrine tumor, etc.
✕. Time since treatment initiation greater than 6 months
✕. Protected persons (pregnant women, breastfeeding women, individuals under guardianship or curators, minors, persons deprived of liberty, or persons unable to express informed consent).

What they're measuring

First symptom(s) and the histological diagnosis

Timeframe: At the inclusion

Trial details

NCT IDNCT07455942

SponsorCentre Hospitalier Intercommunal Creteil

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-09-30

Contact for this trial

ISABELLE ETIENNEY

(0)1 44 64 20 16 51 ietienney@hopital-dcss.org

View on ClinicalTrials.gov More Squamous Cell Carcinoma of the Anal Canal trials